BioGem
$FENC Holding my long since last year. This company is a beast.
-Excellent beat on top and bottom lines.
-High margins with solid profits and positive cash flows.
-No competitor in their niche = mini-monopoly.
-High-quality management leading a high productivity sales team.
-Market is still under-penetrated = growth rates to stay high for a while.
-Ex-US milestones and royalties haven't even started contributing yet.
-Low short interest.
-Analyst will be rising price targets further. $XBI $XLV
2

:format(webp)/https%3A%2F%2Fstaticx-tuner.zacks.com%2Fimages%2Fdefault_article_images%2Fdefault32.jpg)